Jeffrey B. Mirviss - 13 Feb 2025 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role
EVP&Pres, Periph Intervent
Signature
/s/ Susan Thompson, Attorney-in-Fact
Issuer symbol
BSX
Transactions as of
13 Feb 2025
Net transactions value
-$439,508
Form type
4
Filing time
18 Feb 2025, 17:52:13 UTC
Previous filing
14 Feb 2025
Next filing
19 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BSX Common Stock Options Exercise $0 +2,776 +9.3% $0.000000 32,477 14 Feb 2025 Direct F1
transaction BSX Common Stock Tax liability $134,335 -1,266 -3.9% $106.11 31,211 14 Feb 2025 Direct
transaction BSX Common Stock Options Exercise $0 +2,970 +9.5% $0.000000 34,181 16 Feb 2025 Direct F1
transaction BSX Common Stock Tax liability $143,779 -1,355 -4% $106.11 32,826 16 Feb 2025 Direct
transaction BSX Common Stock Options Exercise $0 +3,334 +10% $0.000000 36,160 17 Feb 2025 Direct F1
transaction BSX Common Stock Tax liability $161,393 -1,521 -4.2% $106.11 34,639 17 Feb 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BSX Restricted Stock Units Award $0 +5,181 $0.000000 5,181 13 Feb 2025 Common Stock 5,181 Direct F1, F2
transaction BSX Stock Option (Right to Buy) Award $0 +13,334 $0.000000 13,334 13 Feb 2025 Common Stock 13,334 $106.14 Direct F3
transaction BSX Restricted Stock Units Options Exercise $0 -2,776 -33% $0.000000 5,552 14 Feb 2025 Common Stock 2,776 Direct F1, F4
transaction BSX Restricted Stock Units Options Exercise $0 -2,970 -50% $0.000000 2,970 16 Feb 2025 Common Stock 2,970 Direct F1, F5
transaction BSX Restricted Stock Units Options Exercise $0 -3,334 -100% $0.000000 0 17 Feb 2025 Common Stock 3,334 Direct F1, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F2 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 13, 2026, the first anniversary of the date of grant.
F3 Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 13, 2026, the first anniversary of the date of grant.
F4 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 14, 2024, the first anniversary of the date of grant.
F5 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant.
F6 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant.